Study summary

This study will test a drug called enfortumab vedotin in participants with a type of bladder cancer called non-muscle invasive bladder cancer (NMIBC).

This study will also evaluate what the side effects are and if the drug works to treat NMIBC. A side effect is anything a drug does to your body besides treating your disease.

In this study enfortumab vedotin will be put into the bladder using a catheter. A catheter is a thin tube that can be put into your bladder.

Additional Study Details

Phase
Phase 1
Product
  • Enfortumab vedotin
  • Type
    Interventional
    Masking
    None (Open Label)
    Enrollment number
    58
    Show Additional Study Details

    Get more information

    Would you like more information about clinical trial sites that are recruiting participants for A Study of Intravesical Enfortumab Vedotin For Treatment of Patients With Non-muscle Invasive Bladder Cancer (NMIBC)? Contact us by filling out your information to the right and we’ll respond to you.

    • A patient
    • A caregiver
    • A parent
    • A healthcare provider
    • A patient advocate
    • Algeria
    • Argentina
    • Armenia
    • Australia
    • Austria
    • Belarus
    • Belgium
    • Bosnia And Herzegovina
    • Brazil
    • Bulgaria
    • Canada
    • Chile
    • China
    • Colombia
    • Croatia
    • Czech Republic
    • Denmark
    • Dominican Republic
    • Egypt
    • Estonia
    • Finland
    • Former Serbia and Montenegro
    • France
    • Georgia
    • Germany
    • Greece
    • Guatemala
    • Hong Kong
    • Hungary
    • Iceland
    • India
    • Indonesia
    • Ireland
    • Israel
    • Italy
    • Japan
    • Jordan
    • Kazakhstan
    • Latvia
    • Lebanon
    • Lithuania
    • Macedonia
    • Malaysia
    • Mexico
    • Montenegro
    • Morocco
    • Netherlands
    • New Zealand
    • Norway
    • Panama
    • Peru
    • Philippines
    • Poland
    • Portugal
    • Puerto Rico
    • Republic of Korea
    • Republic of Moldova
    • Romania
    • Russian Federation
    • Saudi Arabia
    • Serbia
    • Singapore
    • Slovakia
    • Slovenia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Taiwan, Province of China
    • Thailand
    • Turkey
    • Ukraine
    • United Kingdom
    • United States
    • Vietnam

    By clicking ["Continue/Submit"], you agree that Astellas may contact you by email with information to help you connect with clinical trial sites. While we can connect you to clinical trial sites, we cannot answer questions about any investigational therapy through email. Your consent to receiving emails is not a requirement to participate in a clinical trial or study. For more information, including how to unsubscribe at any time, see our Privacy Notice & Cookies Policy.

      Locations

      Contact Us
      Contact Us
      Recruiting
      MD Anderson
      Houston, TX, United States, 77030
      Completed
      Laura & Isaac Perlmutter Cancer Center at NYU Langone Health
      New York, NY, United States, 10016
      Recruiting
      Johns Hopkins Medical Center
      Baltimore, MD, United States, 21287
      Completed
      Duke University Medical Center
      Durham, NC, United States, 27710
      Recruiting
      University of California, Irvine
      Orange, CA, United States, 92868
      Recruiting
      Site ES34001
      Barcelona, Spain, 08025
      Recruiting
      University of Texas Southwestern Medical Center
      Dallas, TX, United States, 75390
      Recruiting
      Site CA11001
      Toronto, Ontario, Canada, M5G 2C1
      Recruiting
      Site FR33001
      Paris, France, 75013
      Recruiting
      University of California at San Francisco
      San Francisco, CA, United States, 94134
      Recruiting
      Site ES34003
      Barcelona, Spain, 08036
      Recruiting
      Site ES34002
      Madrid, Spain, 28041
      Recruiting
      Site UK44002
      London, United Kingdom, EC1A 7BE
      Recruiting
      UCLA Department of Medicine - Hematology & Oncology
      Los Angeles, CA, United States, 90095
      Recruiting
      Banner MD Anderson Cancer Center
      Gilbert, Arizona, United States, 85234
      Recruiting
      James Cancer Hospital / Ohio State University
      Columbus, Ohio, United States, 43221
      Recruiting
      Carolina Urologic Research Center
      Myrtle Beach, South Carolina, United States, 29572
      Recruiting
      Urology San Antonio
      San Antonio, Texas, United States, 78229
      Recruiting
      Fred Hutchinson Cancer Center / Seattle Cancer Care Alliance / University of Washington
      Seattle, Washington, United States, 98195
      Recruiting
      Mayo Clinic
      Scottsdale, Arizona, United States, 85259
      Recruiting
      Northwestern University-Feinberg School of Medicine
      Chicago, Illinois, United States, 60611
      Recruiting
      Site FR33002
      Lyon, France, 69003
      Recruiting
      Site ES34004
      Barcelona, Spain, 08035
      Recruiting
      Site DE49001
      Goettingen, Germany, 37075
      Recruiting
      Markey Cancer Center / University of Kentucky
      Lexington, Kentucky, United States, 40508
      Recruiting
      Erlanger Oncology and Hematology
      Chattanooga, Tennessee, United States, 37403
      Recruiting
      Site DE49002
      Tübingen, Germany, 72076
      Recruiting
      Sidney Kimmel Cancer Center
      Philadelphia, Pennsylvania, United States, 19107
      Recruiting
      Site FR33003
      Rennes, France, 35000
      Recruiting
      Rush University Medical Center
      Chicago, IL, United States, 60612
      Recruiting
      Stanford Health Care
      Stanford, CA, United States, 94305
      Recruiting
      Oregon Health and Science University
      Portland, OR, United States, 98682

      Frequently Asked Questions

      Are clinical trials only for people with advanced cancer?

      While some clinical trials may focus on more advanced cancers, many trials are open to patients at various stages of their cancer. Each study has rules about who can take part. For example, only patients in a certain age group or those who have a certain type of tumor may be able to join.

      Will I have to stop my current treatment to participate in a clinical trial?

      Sometimes researchers want participants to keep taking their current treatments during a clinical trial. Other times, you may need to stop your current treatments for a while. If the investigational treatment doesn't work, you can usually go back to your original treatment plan.

      Should I be worried about getting a placebo?

      In cancer clinical trials, a placebo is only used if there is no other treatment for that type of cancer. This helps compare an investigational treatment to the placebo. Placebos are rarely used in cancer trials because the best available treatment, called the “standard of care”, is usually given instead.

      Do I need a referral from my doctor to take part in a study?

      Your doctor may not know about all the opportunities for clinical trials that are available to you. Talk to your doctor or other medical provider about clinical trial information that you find. They can help you decide if a clinical trial is right for you. If you do not find any options on this website, we recommend you visit an online public registry website like clinicaltrials.gov to see a wide variety of available clinical trials.

      Explore More

      1

      What are clinical trials?

      2

      Why are Clinical Trials Important?

      3

      Why Participate in a Clinical Trial?